Mostrar el registro sencillo del ítem
dc.contributor.author
Scolnik, Marina
dc.contributor.author
Brance, María Lorena
dc.contributor.author
Fernández Ávila, Daniel G
dc.contributor.author
Inoue Sato, Emilia
dc.contributor.author
de Souza, Alexandre W S
dc.contributor.author
Magri, Sebastián J
dc.contributor.author
Saldarriaga Rivera, Lina M
dc.contributor.author
Ugarte Gil, Manuel F
dc.contributor.author
Flores Suarez, Luis F
dc.contributor.author
Babini, Alejandra
dc.contributor.author
Zamora, Natalia V
dc.contributor.author
Acosta Felquer, María L
dc.contributor.author
Vergara, Facundo
dc.contributor.author
Carlevaris, Leandro
dc.contributor.author
Scarafia, Santiago
dc.contributor.author
Soriano Guppy, Enrique Roberto
dc.contributor.author
Unizony, Sebastian
dc.date.available
2023-11-23T12:07:52Z
dc.date.issued
2022-12
dc.identifier.citation
Scolnik, Marina; Brance, María Lorena; Fernández Ávila, Daniel G; Inoue Sato, Emilia; de Souza, Alexandre W S; et al.; Pan American League of Associations for Rheumatology guidelines for the treatment of giant cell arteritis; Elsevier; The Lancet Rheumatology; 4; 12; 12-2022; e864-e872
dc.identifier.uri
http://hdl.handle.net/11336/218517
dc.description.abstract
Considerable variability exists in the way that health-care providers treat patients with giant cell arteritis in Latin America, with patients commonly exposed to excessive amounts of glucocorticoids. In addition, large health disparities prevail in this region due to socioeconomic factors, which influence access to care, including biological treatments. For these reasons, the Pan American League of Associations for Rheumatology developed the first evidence-based giant cell arteritis treatment guidelines tailored for Latin America. A panel of vasculitis experts from Mexico, Colombia, Peru, Brazil, and Argentina generated clinically meaningful questions related to the treatment of giant cell arteritis in the population, intervention, comparator, and outcome (PICO) format. Following the grading of recommendations, assessment, development, and evaluation methodology, a team of methodologists did a systematic literature search, extracted and summarised the effects of the interventions, and graded the quality of the evidence. The panel of vasculitis experts voted on each PICO question and made recommendations, which required at least 70% agreement among the voting members to be included in the guidelines. Nine recommendations and one expert opinion statement for the treatment of giant cell arteritis were developed considering the most up-to-date evidence and the socioeconomic characteristics of Latin America. These recommendations include guidance for the use of glucocorticoids, tocilizumab, methotrexate, and aspirin for patients with giant cell arteritis.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.subject
Guidelines
dc.subject
Treatment
dc.subject
Giant cell arteritis
dc.subject.classification
Reumatología
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Pan American League of Associations for Rheumatology guidelines for the treatment of giant cell arteritis
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2023-11-15T15:54:06Z
dc.identifier.eissn
2665-9913
dc.journal.volume
4
dc.journal.number
12
dc.journal.pagination
e864-e872
dc.journal.pais
Reino Unido
dc.journal.ciudad
Londres
dc.description.fil
Fil: Scolnik, Marina. Hospital Italiano; Argentina
dc.description.fil
Fil: Brance, María Lorena. Universidad Nacional de Rosario; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario; Argentina
dc.description.fil
Fil: Fernández Ávila, Daniel G. Pontificia Universidad Javeriana; Colombia
dc.description.fil
Fil: Inoue Sato, Emilia. Universidade Federal de Sao Paulo; Brasil
dc.description.fil
Fil: de Souza, Alexandre W S. Universidade Federal de Sao Paulo; Brasil
dc.description.fil
Fil: Magri, Sebastián J. Hospital Italiano; Argentina
dc.description.fil
Fil: Saldarriaga Rivera, Lina M. Hospital Universitario San Jorge; Colombia
dc.description.fil
Fil: Ugarte Gil, Manuel F. Universidad Cientifica del Sur;
dc.description.fil
Fil: Flores Suarez, Luis F. Instituto Nacional de Enfermedades Respiratorias; México
dc.description.fil
Fil: Babini, Alejandra. Hospital Italiano; Argentina
dc.description.fil
Fil: Zamora, Natalia V. Hospital San José; Argentina
dc.description.fil
Fil: Acosta Felquer, María L. Hospital Italiano; Argentina
dc.description.fil
Fil: Vergara, Facundo. Gobierno de la Provincia de Mendoza. Hospital Central de Mendoza.; Argentina
dc.description.fil
Fil: Carlevaris, Leandro. Hospital Privado de Mendoza; Argentina
dc.description.fil
Fil: Scarafia, Santiago. Hospital Municipal San Cayetano; Argentina
dc.description.fil
Fil: Soriano Guppy, Enrique Roberto. Hospital Italiano; Argentina
dc.description.fil
Fil: Unizony, Sebastian. Harvard Medical School; Estados Unidos
dc.journal.title
The Lancet Rheumatology
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/S2665-9913(22)00260-0
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S2665991322002600
Archivos asociados